Dr. Beatrice Y. Brewington

I specialize in the diagnosis and treatment of patients with ocular tumors, including benign and malignant tumors of the eye. I have been working in this field for more than 20 years. Cancer of the eye is a rare disease, but once the tumor is found we begin the treatment process; the key is to be diagnosed and treated timely and correctly. My goal is to improve the prognosis of these rare eye diseases in terms of life, conservation of the eye and sight. There is a large team dedicated to ocular oncology at Duke Health. I work very closely with colleagues across Duke Eye Center and from Duke Cancer Center, specialists in children and adults, to develop the best diagnosis and treatment plans for patients suffering from cancer of the eye with the mission of providing optimal prognosis for life, eye and vision preservation. Dr. Materin is rated as a Distinguished provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Choroid Plexus Carcinoma.

Wajiha Kheir is an Ophthalmologist in Durham, North Carolina. Dr. Kheir is rated as an Advanced provider by MediFind in the treatment of Uveal Melanoma. Her top areas of expertise are Melanoma of the Eye, Tuberculous Uveitis, Metastatic Uveal Melanoma, and Uveal Melanoma. Dr. Kheir is currently accepting new patients.

As a medical retina specialist, I am passionate about providing state-of-the-art care to patients with age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and other macular diseases. I approach each patient as an individual and strive to provide care that addresses his or her unique needs and goals. For each of my patients, I carefully consider exam findings and results of advanced retinal imaging studies and use this information to design a personalized treatment strategy. In my role as a physician, I enjoy most the enduring relationships that I build with patients and their families, and the opportunities that I have to make a lasting positive impact on their lives. In addition to patient care, I maintain an active clinical and laboratory research program. I am actively involved in clinical trials of new treatments for age-related macular degeneration and diabetic retinopathy, and in studies of new imaging technologies for improved diagnosis and monitoring of macular diseases. Outside of work, I enjoy spending time with my wife and children. Dr. Mettu is rated as a Distinguished provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, and Diabetic Retinopathy.